Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

AstraZeneca's failed cancer drug gets new lease on life thanks to positive kidney disease data
Fierce Biotech
Fri, 11/3/23 - 11:55 am
Tags:
AstraZeneca, zibotentan, chronic kidney disease
HHS Challenges AstraZeneca’s Motion for Summary Judgement in IRA Lawsuit
BioSpace
Fri, 11/3/23 - 10:58 am
Tags:
AstraZeneca, legal, HHS, Inflation Reduction Act
Merck's Keytruda nabs FDA nod in biliary tract cancer, catching up with AstraZeneca's Imfinzi
Fierce Pharma
Wed, 11/1/23 - 10:10 pm
Tags:
Merck, AstraZeneca, biliary tract cancer, Keytruda, Imfinzi
AstraZeneca Drops $245M on Cell and Gene Therapies in Deal with Cellectis
BioSpace
Wed, 11/1/23 - 11:07 am
Tags:
AstraZeneca, Cellectis, cell therapy, gene therapy
Merck KGaA pays $169M for selective PARP1 drug, stepping up challenge to AstraZeneca and Gilead
Fierce Biotech
Mon, 10/30/23 - 11:58 am
Tags:
Merck KGaA, PARP inhibitors, Lynparza, Zejula, AstraZeneca, Gilead Sciences, solid tumors
[podcast]AstraZeneca’s Arun Krishna says Tagrisso-based combo promises new option in lung cancer
Medical Marketing and Media
Thu, 10/26/23 - 10:37 am
Tags:
AstraZeneca, Arun Krishna, Tagrisso, lung cancer
ESMO: AstraZeneca aims for ‘2.0’ cancer pipeline, shares bispecific data
Fierce Biotech
Tue, 10/24/23 - 07:52 pm
Tags:
AstraZeneca, cancer, oncology, bispecifics
AZ seeks FDA okay for first self-administered flu vaccine
Pharmaphorum
Tue, 10/24/23 - 10:03 am
Tags:
AstraZeneca, FDA, FluMist Quadrivalent, vaccines, flu vaccines, self-administered vaccines
ESMO: AstraZeneca-Daiichi get clarity on patient deaths for Enhertu follow up Dato-DXd, survival data still unclear
Fierce Biotech
Mon, 10/23/23 - 05:22 pm
Tags:
ESMO, Daiichi Sankyo, AstraZeneca, Enhertu, patient deaths, clinical trials, non-small cell lung cancer
ESMO: AstraZeneca proposes adding Lynparza to Imfinzi as endometrial cancer race heats up
Fierce Pharma
Mon, 10/23/23 - 09:07 am
Tags:
ESMO, AstraZeneca, Merck, Lynparza, endometrial cancer
Lung Cancer Takes Center Stage at ESMO Congress 2023 With New Drugs, More Options
OBR Oncology
Fri, 10/20/23 - 10:05 am
Tags:
ESMO, non-small cell lung cancer, Roche, Alecensa, AstraZeneca, Tagrisso, JNJ, Rybrevant
Merck pays $4B upfront for rights to 3 Daiichi ADCs in huge bet on post-Keytruda future
Fierce Biotech
Fri, 10/20/23 - 09:55 am
Tags:
Merck, Daiichi Sankyo, AstraZeneca, antibody-drug conjugate
Could J&J’s Rybrevant-based combo disrupt AstraZeneca’s Tagrisso in lung cancer faceoff?
Medical Marketing and Media
Thu, 10/19/23 - 11:29 am
Tags:
JNJ, Rybrevant, AstraZeneca, Tagrisso, EGFR-mutated NSCLC
AZ’s Tagrisso plus chemo get fast FDA review for lung cancer
Pharmaphorum
Mon, 10/16/23 - 10:20 am
Tags:
AstraZeneca, FDA, Tagrisso, non-small cell lung cancer, EGFR-positive non-small cell lung cancer
AstraZeneca Settles Lawsuits Alleging Heartburn Drugs Caused Kidney Disease For $425 Million
Forbes
Tue, 10/3/23 - 11:34 am
Tags:
AstraZeneca, legal, kidney disease, heartburn, Nexium, Prilosec
J&J's lung cancer therapy succeeds in head-to-head study with AstraZeneca's drug
Reuters
Thu, 09/28/23 - 12:08 pm
Tags:
JNJ, non-small cell lung cancer, AstraZeneca, Rybrevant, lazertinib, Tagrisso
AstraZeneca, BMS Reluctantly Agree to Medicare Drug Price Negotiation Program
BioSpace
Wed, 09/27/23 - 11:57 am
Tags:
AstraZeneca, Bristol Myers Squibb, drug pricing, Inflation Reduction Act, Medicare
AstraZeneca, Daiichi Tout Phase III Breast Cancer Data in Challenge to Gilead
BioSpace
Fri, 09/22/23 - 11:51 am
Tags:
AstraZeneca, Daiichi Sankyo, breast cancer, antibody-drug conjugate, clinical trials
AstraZeneca refused to pay full bonus to US remote worker, lawsuit claims
Reuters
Thu, 09/21/23 - 11:57 am
Tags:
AstraZeneca, legal, remote work, employment law
AZ's Alexion inks $125M deal to resolve investor lawsuit over Soliris sales tactics
Fierce Pharma
Thu, 09/14/23 - 11:00 pm
Tags:
Alexion, AstraZeneca, Soliris, investors, legal

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.